Ongentys is a medication that has been approved by the FDA for the treatment of Parkinson’s disease. It is specifically indicated for use in combination with levodopa/carbidopa in patients who are experiencing motor fluctuations. Ongentys works by inhibiting the enzyme catechol-O-methyltransferase (COMT), which helps to prolong the effects of levodopa and reduce the “off” time experienced by patients.

As a medical professional, I recommend Ongentys to my patients who are struggling with motor fluctuations despite being on levodopa therapy. By adding Ongentys to their treatment regimen, we can often see improvements in their symptoms and overall quality of life. It is important to note that Ongentys is not a standalone treatment for Parkinson’s disease and should always be used in combination with levodopa/carbidopa.

Like all medications, Ongentys does come with potential side effects. These can include dyskinesia, constipation, and hallucinations. It is important for patients to be aware of these potential side effects and to report any new or worsening symptoms to their healthcare provider.

Overall, Ongentys has been shown to be an effective and well-tolerated treatment option for patients with Parkinson’s disease who are experiencing motor fluctuations. As a medical professional, I am confident in recommending Ongentys to my patients and believe that it can make a positive impact on their lives.